Clinical Trial Imaging Market Report: Trends, Forecast and Competitive Analysis to 2030
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
1. EXECUTIVE SUMMARY
2. GLOBAL CLINICAL TRIAL IMAGING MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Clinical Trial Imaging Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Clinical Trial Imaging Market by Product & Services
3.3.1: Software
3.3.2: Services
3.4: Global Clinical Trial Imaging Market by Modality
3.4.1: Computed Tomography
3.4.2: Magnetic Resonance Imaging
3.4.3: Ultrasound
3.4.4: Positron Emission Tomography
3.4.5: X-ray
3.4.6: Echocardiography
3.5: Global Clinical Trial Imaging Market by Therapeutic Area
3.5.1: Oncology
3.5.2: Infectious Diseases
3.5.3: Neurology
3.5.4: CVS
3.5.5: Endocrinology
3.5.6: Immunological Disorder
3.6: Global Clinical Trial Imaging Market by End Use
3.6.1: Pharmaceutical Companies
3.6.2: Biotechnology Companies
3.6.3: Medical Device Manufacturer
3.6.4: Contract Research Organizations
3.6.5: Academic and Government Research Institutes
3.6.6: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Clinical Trial Imaging Market by Region
4.2: North American Clinical Trial Imaging Market
4.2.2: North American Clinical Trial Imaging Market by End Use: Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturer, Contract Research Organizations, Academic & Government Research Institutes, and Others
4.3: European Clinical Trial Imaging Market
4.3.1: European Clinical Trial Imaging Market by Modality: Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Positron Emission Tomography, X-ray, and Echocardiography
4.3.2: European Clinical Trial Imaging Market by End Use: Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturer, Contract Research Organizations, Academic & Government Research Institutes, and Others
4.4: APAC Clinical Trial Imaging Market
4.4.1: APAC Clinical Trial Imaging Market by Modality: Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Positron Emission Tomography, X-ray, and Echocardiography
4.4.2: APAC Clinical Trial Imaging Market by End Use: Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturer, Contract Research Organizations, Academic & Government Research Institutes, and Others
4.5: ROW Clinical Trial Imaging Market
4.5.1: ROW Clinical Trial Imaging Market by Modality: Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Positron Emission Tomography, X-ray, and Echocardiography
4.5.2: ROW Clinical Trial Imaging Market by End Use: Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturer, Contract Research Organizations, Academic & Government Research Institutes, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Clinical Trial Imaging Market by Product & Services
6.1.2: Growth Opportunities for the Global Clinical Trial Imaging Market by Modality
6.1.3: Growth Opportunities for the Global Clinical Trial Imaging Market by Therapeutic Area
6.1.4: Growth Opportunities for the Global Clinical Trial Imaging Market by End Use
6.1.5: Growth Opportunities for the Global Clinical Trial Imaging Market by Region
6.2: Emerging Trends in the Global Clinical Trial Imaging Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Clinical Trial Imaging Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Clinical Trial Imaging Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: ICON
7.2: Biotelemetry
7.3: Medpace Holdings
7.4: Biomedical Systems Corporation
7.5: Bioclinica
7.6: IXICO
7.7: Resonance Health
7.8: Radiant Sage
7.9: Intrinsic Imaging
7.10: Cardiovascular Imaging Technologies
2. GLOBAL CLINICAL TRIAL IMAGING MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Clinical Trial Imaging Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Clinical Trial Imaging Market by Product & Services
3.3.1: Software
3.3.2: Services
3.4: Global Clinical Trial Imaging Market by Modality
3.4.1: Computed Tomography
3.4.2: Magnetic Resonance Imaging
3.4.3: Ultrasound
3.4.4: Positron Emission Tomography
3.4.5: X-ray
3.4.6: Echocardiography
3.5: Global Clinical Trial Imaging Market by Therapeutic Area
3.5.1: Oncology
3.5.2: Infectious Diseases
3.5.3: Neurology
3.5.4: CVS
3.5.5: Endocrinology
3.5.6: Immunological Disorder
3.6: Global Clinical Trial Imaging Market by End Use
3.6.1: Pharmaceutical Companies
3.6.2: Biotechnology Companies
3.6.3: Medical Device Manufacturer
3.6.4: Contract Research Organizations
3.6.5: Academic and Government Research Institutes
3.6.6: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Clinical Trial Imaging Market by Region
4.2: North American Clinical Trial Imaging Market
4.2.2: North American Clinical Trial Imaging Market by End Use: Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturer, Contract Research Organizations, Academic & Government Research Institutes, and Others
4.3: European Clinical Trial Imaging Market
4.3.1: European Clinical Trial Imaging Market by Modality: Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Positron Emission Tomography, X-ray, and Echocardiography
4.3.2: European Clinical Trial Imaging Market by End Use: Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturer, Contract Research Organizations, Academic & Government Research Institutes, and Others
4.4: APAC Clinical Trial Imaging Market
4.4.1: APAC Clinical Trial Imaging Market by Modality: Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Positron Emission Tomography, X-ray, and Echocardiography
4.4.2: APAC Clinical Trial Imaging Market by End Use: Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturer, Contract Research Organizations, Academic & Government Research Institutes, and Others
4.5: ROW Clinical Trial Imaging Market
4.5.1: ROW Clinical Trial Imaging Market by Modality: Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Positron Emission Tomography, X-ray, and Echocardiography
4.5.2: ROW Clinical Trial Imaging Market by End Use: Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturer, Contract Research Organizations, Academic & Government Research Institutes, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Clinical Trial Imaging Market by Product & Services
6.1.2: Growth Opportunities for the Global Clinical Trial Imaging Market by Modality
6.1.3: Growth Opportunities for the Global Clinical Trial Imaging Market by Therapeutic Area
6.1.4: Growth Opportunities for the Global Clinical Trial Imaging Market by End Use
6.1.5: Growth Opportunities for the Global Clinical Trial Imaging Market by Region
6.2: Emerging Trends in the Global Clinical Trial Imaging Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Clinical Trial Imaging Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Clinical Trial Imaging Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: ICON
7.2: Biotelemetry
7.3: Medpace Holdings
7.4: Biomedical Systems Corporation
7.5: Bioclinica
7.6: IXICO
7.7: Resonance Health
7.8: Radiant Sage
7.9: Intrinsic Imaging
7.10: Cardiovascular Imaging Technologies
